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CRISPR/Cas mediated genome editing has been successfully demonstrated in mammalian cells and further
applications for generating mutant mice were reported by injecting humanized Cas9 (hCas) mRNA and
single guide RNA into fertilized eggs. Here we inject the circular plasmids expressing hCas9 and sgRNA into
mouse zygotes and obtained mutant mice within a month. When we targeted the Cetn1 locus, 58.8% (10/17)
of the pups carried the mutations and six of them were homozygously mutated. Co-injection of the plasmids
targeting different loci resulted in the successful removal of the flanked region in two out of three mutant
pups. The efficient mutagenesis was also observed at the Prm1 locus. Among the 46 offspring carrying
CRISPR/Cas plasmid mediated mutations, only two of them carried the hCas9 transgene. The pronuclear
injection of circular plasmid expressing hCas9/sgRNA complex is a rapid, simple, and reproducible method
for targeted mutagenesis.
G
ene knockout animals are a robust tool for elucidating the roles of numerous genes in development,
growth, adult physiology, and disease1. For designed mutagenesis, the drug resistant gene has been
traditionally introduced into the genome through homologous recombination in embryonic stem (ES)
cells, chimeric mice production and germ-line transmission by mating experiments2. Although it is a widely used
approach, it is laborious, costly, and time consuming. Moreover, only well trained researchers are able to
accomplish all experimental procedures.
The emergence of zinc-finger nucleases (ZFN) and/or transcription activator-like effector nucleases (TALEN)
have opened the window for the next generation of targeted mutagenesis3. These enzymes are artificially
generated by fusing FokI endonucleases with DNA recognition motifs. The enzymes recognize target DNA by
peptide-DNA affinity and fused FokI nucleases generate double strand breaks (DSB), subsequently error-prone
non-homologous end joining (NHEJ) results in small indels3. Moreover, if reference ssDNA or dsDNA exists,
homology dependent repair (HDR) or high-fidelity homologous recombination (HR) introduces designed muta-
tions into the targeted locus4. Since the DSB mediated mutation is efficient, one-step generation of gene targeted
mice and rats have been reported by injecting the mRNA coding these enzymes into zygotes5,6. However, the
difficulty in the design and preparation of these enzymes hampered the spreading of the technique.
Recently, the type II CRISPR (Clustered regulatry interspaced short palindromic repeat)/Cas (CRISPR assoc-
iated) system has been demonstrated to cause DSB in mammalian cells7,8. The CRISPR/Cas system was originally
found in bacteria and archaea and has turned out to be an RNA-based adaptive immune system to destroy
invading plasmids, phages, and viruses9–11. The nucleoprotein complex consisting of CRISPR coded RNAs
(crRNAs), trans-activating crRNAs (tracrRNA), and Cas proteins, recognize foreign DNA by the crRNA
sequences and degrade it by endonuclease activity12. It is noteworthy that the combination of the humanized
Cas9 (hCas9) protein with synthetic single-guide RNA (sgRNA) generated by fusing crRNA and tracrRNA could
reconstitute RNA-based nucleases and cause DSB in mammalian cells7,8. The indels caused by error-prone NHEJ
leads to targeted gene mutation.
In the present report, we have developed a simple validation system for the gene targeted DSB by observing
green fluorescence reconstituted by HDR of an EGFP expression cassette (Fig. 1a). Different from ZFNs and
TALENs, gene targeting ribonuclear complexes can easily be designed and prepared by changing sgRNA
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sgRNA expression cassette. After the validation in vitro, we injected
the plasmid into fertilized mouse eggs in it’s circular form to decrease
the chance of integration into the genome. Finally, gene targeting
efficiency and transgenicity were examined as well as off-target clea-
vages. Whereas Wang et al13., demonstrated one-step generation of
mice carrying mutations by injecting hCas9 mRNA with sgRNA into
zygotes, our method can skip the mRNA and sgRNA synthesis and
provide simple and reproducible method for targeted mutagenesis.
Results
Preparation of the CRISPR/Cas plasmids for genome engineering.
Activity of gene-targeted endonucleases have been traditionally
validated by Cel-I nuclease digestion of PCR amplified targeted re-
gion and/or the single strand annealing (SSA) assay that reconstitutes
reporter gene expression14. Here we prepared the pCAG-EGxxFP
plasmid containing 59 and 39 EGFP fragments that share 482 bp
under ubiquitous CAG promoter15 (Fig. 1b). An approximately
500 bp region of the target genome was inserted between the EGFP
fragments and used as a target plasmid. For expressing hCas9 and
sgRNA, pX330 plasmid prepared by Dr. Feng Zhang was used7. To
validate which sgRNA sequence works, we cotransfected the pCAG-
EGxxFP-target and pX330-sgRNA plasmids into HEK293T cells and
the reconstituted EGFP fluorescence was observed 48 hrs after
transfection (Fig. 1c). With effective sgRNA sequences, more than
30% of the transfected cells became fluorescent. The oligos and
primers as we used are listed in Table S1.
One-step generation of gene mutant mice by microinjection into
the zygotes. Following validation of sgRNA containing pX330
plasmids in human 293T cells, we used two approaches to generate
gene targeted mutant mice by zygote injection (Fig 1d). First, we
constructed plasmids in which hCas9 and sgRNA is placed under
T7 promoter (Fig. 1b). In vitro transcribed hCas9 mRNA was 59-
capped, 39-polyadenylated, and then injected with sgRNA. Secondly,
to minimize the steps and efforts, we directly injected pX330-sgRNA
plasmids into pronuclei of fertilized eggs. The pups developed from
these eggs were genotyped by PCR and subsequent sequence analysis.
When we examined Centrin 1 (Cetn1) and Protamine 1 (Prm1)
loci, microinjection of hCas9 mRNA along with sgRNA efficiently
caused indels at the targeted locus (Fig. 2, Table 1). Consistent with
the recent report13, the mutation frequency appeared to depend on
RNA concentration and all four pups developed from eggs injected
with hCas9 mRNA and sgRNA at 40 and 10 ng/ul, respectively,
carried the mutation at the Prm1 loci.
When the pX330 plasmids were injected at five ng/ul, 58.8% (10/
17) of pups carried the targeted mutation at the Cetn1 locus (Table 2).
Figure 1 | Scheme for CRISPR/Cas mediated gene manipulation. (a) pCAG-EGxxFP plasmid contains 59 and 39 EGFP fragments that shares 482 bp
under ubiquitous CAG promoter. The ,500 bp genomic fragment containing the sgRNA target sequence was placed between EGFP fragments of pCAG-
EGxxFP plasmid. The resulting target plasmid was cotransfected with pX330 plasmids expressing sgRNA and hCas9 into HEK293T cells. When the target
sequence was digested by sgRNA guided CAS9 endonuclease, the homology dependent repair (HR; homologous recombination or SSA: single strand
annealing) took place and reconstituted the EGFP expression cassette. MCS; multi cloning sites. (b) The plasmids used in the study. pCAG-EGxxFP
contains multicloning sites (BamHI, NheI, PstI, SalI, EcoRI, and EcoRV). pX330 and pT7-sgRNA plasmids contains BbsI sites that enables directional
cloning of sgRNA oligos7. (c) The efficiency of DSB mediated homology dependent repair was validated by observing EGFP fluorescence 48 hrs after the
transfection (top; pX330 without sgRNA, bottom; pX330 with Cetn1/sgRNA1). (d) To generate gene disrupted mice, fertilized eggs were injected with
RNAs coding hCas9 and sgRNA into cytoplasm or pX330 plasmid into pronuclei.
www.nature.com/scientificreports
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Figure 2 | CRISPR/Cas mediated Cetn1 and Prm1 mutations in mice. (a) Cetn1 mutations observed in founder mice. The small indels were identified at
sgRNA targeted locus (bold; sgRNA recognition site, red; PAM sequence, slash; predicted cleavage site, and arrow; sgRNA direction). Some mutations
were frequently observed in independent founder mice. The numbers of mutants obtained were indicated in parenthesis (left; with plasmid injection,
right; with RNA injection). (b) Representative Cetn1 genomic sequences from founder mice (top; wild type, middle; heterozygous 8 bp deletion,
homozygous 8 bp deletion). (c and d) Prm1 mutations observed in founder mice.
Table 1 | Generation of mutant mice via hCas9 mRNA and sgRNA injection
target hCas95sgRNA (ng/uL) injected two-cell/survived GMO/pups hetero5homo
Cetn1 1051 67 52/54 (96.3%) 5/20 (25.0%) 550
1051 72 45/45 (100%) 0/5 (0%) -
Prm1 10510 51 33/35 (94.3%) 7/15 (46.7%) 750
40510 23 15/16 (93.8%) 4/4 (100%) 450
hCas9 mRNA and sgRNA were mixed and injected into mouse zygotes. The injected eggs were transferred into pseudopregnant females. The mutations were identified by sequencing PCR amplified
0.5 kbp genomic fragment containing target in the center. GMO; gene modified organism.
www.nature.com/scientificreports
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It is noteworthy that we could not detect any wild-type signals in six
among the 10 mutants, suggesting these were homozygously mutated
at the targeted locus (Fig. 2b). Prior to the further analysis, all the tail
tip DNA samples collected from the mutant mice were subjected to
PCR analysis. Among the 46 mutants obtained with nine pX330
constructs (Cetn1, Prm1, and 7 other targets), only two pups carried
the hCas9 transgene.
CRISPR/Cas mediated deletion between two loci. To examine
whether the region flanked by two target loci can be removed, we
coinjected the two pX330 plasmids targeting separate regions 381 bp
apart in the Cetn1 gene (predicted cleavage sites). Among the three
mutants obtained, two carried the deletion that removed the region
flanked by the sites targeted by two sgRNAs, sgRNA1 and sgRNA4
(Table 3). Another mutant carried the single mutation at sgRNA1,
which reflected the rate of DSB observed in the HEK293T EGFP
assay, i.e. sgRNA1 demonstrated a better EGFP assay performance
(Table 3).
Off-target analysis in CRISPR/Cas mediated mutants. Although
the single nucleotide exchange within the seed 10 bases of sgRNA
severely diminished its target specificity7, the risk of off-target
mutation remains in Cas9/sgRNA mediated mutant animals. In
the present study, we searched the off-target sites that exactly
matches 12–13 bases at the 39 end and the NGG (N can be A, G,
C, or T) with free software, Bowtie (http://bowtie-bio.sourceforge.
net/index.shtml) against whole mouse genomic sequence (mm9).
There were seven and four off target candidates were found in
Cetn1/sgRNA1 and Prm1/sgRNA1, respectively. We amplified and
sequenced the ,1 kbp regions that contain the potential off-target
sites. A total of 144 off-target sites were analyzed (seven off-target
sites for 16 Cetn1 mutants and four off-target sites for eight Prm1
mutants) and a single off-target mutation was observed in one of the
Cetn1 mutant mice (Table S2).
Male sterility in Cetn1 and Prm1 mutants. Taking advantage of the
homozygous mutant mice generated by pX330 injection, we ana-
lyzed the Cetn1 homozougous mutant mice. As we expected from
the male germ cell specific expression pattern, male Cetn1 mutant
(em4/em4; eight bp deletion, d8) mice were infertile (Fig. 3a).
Although gross morphology of testis looked normal in the mutant
mice, microscopic analysis clarified the impaired ciliogenesis at the
spermatid stage and thus malformed spermatozoa that were unable
to fertilize eggs were generated (Fig. 3b and Fig. S1). When we
analyzed Prm1 mutant mice (wt/em3; five bp deletion, d5), male
infertility with sperm malformation and defective sperm motility
was observed in mutant founder males, indicating haploinsuffi-
ciency of Prm1 gene in mice (Fig. 3c and 3d). These results were
consistent with the reports with conventionally generated Cetn1 and
Prm1 knockout mice, respectively16,17.
Discussion
Development of chimeric nucleases, ZFNs and TALENs, opened the
next-generation of mammalian genome engineering by inducing a
targeted DNA double strand breaks that stimulate error-prone NHEJ
or HDR18,19. However, even after several methods such as Golden-
gate assembly20 have been developed to decrease the steps, difficulties
in preparing the plasmid coding multiple fingers in designed array
hampered the process, preventing its widespread use. Meanwhile an
emergence of the CRISPR/Cas system made this approach more
simple, easy, and cost-effective7,8. It depends on an RNA guided
target DNA recognition system and the CRISPR/Cas mediated
mutagenesis thus far demonstarated in mice has been achieved by
injecting hCas9 mRNA with sgRNA into the zygote13,21.
In the present study, we bypassed the RNA preparation that
requires careful handling and storage, and injected the pX330 plas-
mid that expresses sgRNA and hCas9 under a U6 and chicken beta
actin promoter, respectively7. The efficiency is not able to be directly
compared due to the differences in toxicity, stability, and expression
efficiency, etc between mRNA and plasmids. However, the targeted
mutant animals were competently obtained after the pX330 plasmid
injection (Table 2). In addition, by using circular plasmid, we mini-
mized the risk of undesired transgene integration into host genome22.
Although 4.3% (2/46) of mutant pups carried the hCas9 transgene,
the transgenicity is lower than our average transgenic efficiency with
linearised DNA, 33.4 6 23.0% (173/684, N 5 26 constructs). Thus
we conclude that the direct injection of pX330 into the pronucleus is
a simple, easy, and fast approach to generate targeted gene knockout
mice.
More significantly, we found six out of 10 mutants carried biallelic
mutations at the Cetn1 locus. Thus mice carrying homozygous muta-
tion can be generated within a month (one week for pX330 construc-
tion and three weeks for founder production). Since conventional
gene targeting strateties requires at least eight months to obtain
homozygous mutant (one month for ES cell screening, one month
for chimera production, two months for chimera maturation, one
month for germ line transmission, two months for heterozygote
maturation, one month for homozygous fetal development), it very
much accelerates the mutant mice generation phase. Not only the
Table 2 | Generation of mutant mice via pX330 plasmid injection
target pX330 (ng/uL) injected two-cell/survived GMO/pups hetero5homo
Cetn1 1 91 63/73 (86.3%) 4/10 (40.0%) 450
5 111 61/67 (91.0%) 10/17 (58.8%) 456
Prm1 1 31 10/14 (71.4%) 0/3 (0%) -
5 26 9/18 (50.0%) 2/3 (66.6%) 250
pX330 plasmids containing different sgRNA were injected into mouse zygotes. The injected eggs were transferred into pseudopregnant females. The mutations were identified by sequencing PCR amplified
0.5 kbp genomic fragment containing target in the center. GMO; gene modified organism.
Table 3 | Generation of double mutant mice via pX330 plasmid injection
target pX330-sgRNA (activity in 293T cells#) injected two-cell/survived GMO/pups @15@25excision5wt$
Cetn1 @1 (sgRNA1; 51.7%) @2 (sgRNA4; 31.5%) 71 35/46 (76.1%) 3/5 (60.0%) 1505253
@1 (sgRNA1; 51.7%) @2 (sgRNA3; 12.6%) 129 51/103 (49.5%) 3/12 (25.0%) 3505053
pX330 plasmids targeting 2 different loci were mixed at final 2.5 ng/ul each and injected into mouse zygotes. The injected eggs were transferred into pseudopregnant females. The mutations were
identified by sequencing PCR amplified 0.5 kbp genomic fragment containing targets in the center. GMO; gene modified organism.
#Percent GFP positive cells/transfected 293T cells were indicated in parentesis.
$Number of alleles carrying mutation was indicated.
www.nature.com/scientificreports
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laborious work and the expenses, more importantly animal lives are
also saved. It should be noted that all six homozygous mutants car-
ried the exactly the same mutations in both alleles (one for d1/d1, two
for d8/d8, two for d15/d15, and one for d135/d135). The genomic
DNA hit by a second DSB might refer the firstly mutated DNA to
repair. And/or, as suggested in Wang’s paper13, same micro homo-
logy dependent repair could occur simultaneously within a zygote.
These are consistent with our data that the some mutations are fre-
quently generated independently (Fig. 2a and 2c).
We also showed that multiple DSBs at a different locus occurs in a
zygote. If the target sites are close, the flanked regions were efficiently
removed between target sites (Table 3). Since it is very time-consum-
ing to target two close loci with the traditional ES cell mediated
approach (two rounds of homologous recombination with different
drug selection cassettes), CRISPR/Cas system provides a powerful
tool for mutating the clustered genes. The targeting of multi-loci over
different chromosomes was reported13. Interestingly, single muta-
tions with small indels were more frequently observed in the site
which was targeted more efficiently in vitro (Table 3). This result
implicates that the validation in 293T human cell line is useful prior
to murine zygote injection.
As seen in ZFNs and TALENs, off-target cleavages have been
questioned in the CRISPR/Cas system. In the present study, we
found only one off-targeted mutation in a total of 144 sites examined.
Although it is difficult to compare the off-target risk among these
artificial nucleases, one could argue that ZFNs and TALENs are safer
because they require two adjacent recognition sites while CRISPR/
Cas requires only one target site. On the other hand, whereas ZFNs
and TALENs depend on peptide-nucleotide recognition, CRISPR/
Cas system uses RNA-DNA affinity in which the affinity is high and
easily calculated. Recently, the risk of off-target was claimed with in
vitro studies23,24. Different from the continuous and excess express-
ion in cultured cell lines, transient expression by pronuclear injection
could decrease this risk. The amount of expression is also easily
regulated by changing the concentratio of plasmid to be injected into
the zygote. Since each sgRNA has different off-targets, analysis of an
independent line established with different sgRNAs can minimize
the risk of off-target cleavage effects on the phenotype.
Finally we could observe the effects of Cetn1 and Prm1 deletion in
spermatogenesis. As reported previously16, Prm1 mutant mice
showed a haploinsuficiency phenotype, chromatin mis-folding and
subsequent malformation of the sperm head. As for Cetn1, the
homozygous mutant (em4/em4) showed male infertility with defect-
ive sperm tail elongation, thus generating sperm with impaired
motility. Similar phenotypes were recently reported during our
manuscript preparation17. As we have shown here, the phenotypes
observed in the CRISPR/Cas mediated mutants were the same as in
knockcout mice conventionally generated through ES cells. Here we
conclude the pronuclear injection of circular plasmid expressing
Cas9/gRNA complex is a rapid, simple, and reproducible method
for the targeted mutagenesis in mice and can propel the in vivo gene
function study furhter than ever before. Moreover, athough the large
Figure 3 | Male infertility found in Cetn1 and Prm1 deficient mice. (a) Average litter size obtained from Cetn1 mutant males. Each male was mated with
two B6D2F1 females for two months and numbers of pups were counted at birth. (b) Sperm collected from epidydimis of 12 weeks old males were
photographed under a phase contrast microscopy. Impaired ciliogenesis was observed in Cetn1em4/em4 mice. Scale bar; 20 um. (c) Sperm motility observed
with Prm1 mutant males. The eggs were collected from superovulated B6D2F1 females mated with 12 weeks old males. The sperm motility was anlayzed
by Ceros system at 10 min and 120 min of incubation. (d) Sperm collected from epidydimis of 12 weeks old males were photographed under a differential
interference contrast microscopy. Heads narrowed and reduced in curvature at the tip were observed in most Prm11/em3 sperm. Scale bar; 20 um.
www.nature.com/scientificreports
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scale knockout mice projects are ongoing, thousands of genes (e.g.
sex chromosome linked genes) remained to be targeted because of
the difficulties in vector constrution and gene targeting in ES cells.
We believe that our simple method provides the solution to
complement the current knockout project that is beneficial for the
biological/biomedical researchers worldwide.
Methods
Animals. All animal experiments were approved by the Animal Care and Use
committee of the Research Institute for Microbial Diseases, Osaka University.
Plasmid and mRNA preparation. To construct pCAG-EGxxFP validation plasmid,
N-terminal and C-terminal EGFP coding regions were PCR amplified and placed
under ubiquitous CAG promoter with multicloning sites, BamHI, NheI, PstI, SalI,
EcoRI, and EcoRV. The ,500 bp genomic fragments containing sgRNA target
sequence were PCR amplified and placed between the EGFP fragments. The plasmids
expressing hCas9 and sgRNA were prepared by ligating oligos into BbsI site of pX330
(http://www.addgene.org/42230/)7. As for RNA preparation, sgRNA and hCas9
sequences were removed from pX330 and placed under T7 promoter in pUC19
plasmids and named as pT7-sgRNA and pT7-hCas9, respectively. The resulting
plasmids were subjected to RNA synthesis with mMESSAGE mMACHINE T7 kit
(Ambion, Austin, TX) with manufacturer’s protocol. The hCas9 mRNA was
polyadenlylated with polyA tailing kit (Ambion, Austin, TX) prior to purification
with RNeasy kit (QIAGEN, Chatsworth, CA). The sgRNAs were purified by phenol-
chloroform-isoamylalchol extraction and isopropanol precipitation followed by spin
column chromatography with MicroSpin G-25 (GE Healthcare, Milwaukee, WI).
HEK293T cells transfection. Five handred ng of pCAG-EGxxFP-target was mixed
with 500 ng of pX330 with/without sgRNA sequences and then introduced into 4 3
105 HEK293T cells/well in six well plate by the conventional calcium phosphate
transfection method. The EGFP fluorescence was observed under fluorescence
microscope at 48 hrs after transfection.
Pronuclear injection. B6D2F1 female mice were superovulated and mated with
B6D2F1 males, and fertilized eggs were collected from the oviduct. The pronuclear
stage eggs were injected with pX330 plasmids, hCas9 mRNA, and sgRNAs at
indicated concentrations. The eggs were cultivated in kSOM overnight then
transferred into the oviducts of pseudopregnant ICR females.
Off target analysis. Potential off-target sites were found using a free software, Bowtie
(http://bowtie-bio.sourceforge.net/index.shtml) with rules outlined previously8,13.
Twelve to Thirteen bases preceding the PAM sequence with AGG, GGG, CGG, and
TGG were aligned with mouse genome (mm9). The ,1 kb genomic fragments
containing the off-target in the center were PCR amplified and sequenced.
Male fertility test. Sexually matured Cetn1 mutant male mice were caged with two
month-old B6D2F1 female mice for two months, and the number of pups was
counted at the day of birth. As for Prm1 mutant males, superovulated B6D2F1
females were mated with Prm1 mutant males then the eggs were collected from
copulated females. The fertilization event was confirmed by pronuclear formation at
20 hrs after hCG injection.
Analysis of sperm motility. Epididymal sperm were collected and incubated in a
drop of TYH medium25 covered with liquid paraffin (Nacalai tesque, Kyoto, Japan).
The suspension was then diluted 15100 in TYH medium prior to motility
measurement. Sperm motility was measured using the CEROS sperm analysis system
(software version 12.3; Hamilton Thorne Biosciences, Beverly, MA). Analyasis setting
described previously26 was used.
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